181 related articles for article (PubMed ID: 17435855)
1. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization.
Rosário PW; Reis JS; Fagundes TA; Calsolari MR; Amim R; Silva SC; Purisch S
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):52-8. PubMed ID: 17435855
[TBL] [Abstract][Full Text] [Related]
2. [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
Calsolari MR; Rosário PW; Reis JS; Silva SC; Purisch S
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):315-21. PubMed ID: 18438542
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
Martinka E; Rončáková M; Mišániková M; Davani A
Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
[TBL] [Abstract][Full Text] [Related]
5. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
6. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
Liu L; Li X; Xiang Y; Huang G; Lin J; Yang L; Zhao Y; Yang Z; Hou C; Li Y; Liu J; Zhu D; Leslie RD; Wang X; Zhou Z;
Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
[TBL] [Abstract][Full Text] [Related]
7. [Identification of the two subtypes of latent autoimmune diabetes in adults by glutamic acid decarboxylase 65 antibody titers].
Li X; Zhou ZG; Huang G; Yan X; Yang L; Hu BY
Zhonghua Nei Ke Za Zhi; 2003 Jan; 42(1):7-10. PubMed ID: 12757655
[TBL] [Abstract][Full Text] [Related]
8. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
[TBL] [Abstract][Full Text] [Related]
9. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
[TBL] [Abstract][Full Text] [Related]
11. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
Li X; Huang G; Yan X; Yang L; Zhou ZG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648
[TBL] [Abstract][Full Text] [Related]
12. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z
Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
14. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
16. Latent Autoimmune Diabetes in Adults in North Indian Region: Assessment of β-Cell Function, Metabolic and Immunological Features.
Kumar A; de Leiva A
Metab Syndr Relat Disord; 2017 Dec; 15(10):494-499. PubMed ID: 29040050
[TBL] [Abstract][Full Text] [Related]
17. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhou Z; Xiang Y; Ji L; Jia W; Ning G; Huang G; Yang L; Lin J; Liu Z; Hagopian WA; Leslie RD;
Diabetes; 2013 Feb; 62(2):543-50. PubMed ID: 23086039
[TBL] [Abstract][Full Text] [Related]
18. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.
Littorin B; Sundkvist G; Hagopian W; Landin-Olsson M; Lernmark A; Ostman J; Arnqvist HJ; Blohmé G; Bolinder J; Eriksson JW; Lithner F; Scherstén B; Wibell L
Diabetes Care; 1999 Mar; 22(3):409-12. PubMed ID: 10097919
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity among patients with latent autoimmune diabetes in adults.
Maruyama T; Nakagawa T; Kasuga A; Murata M
Diabetes Metab Res Rev; 2011 Nov; 27(8):971-4. PubMed ID: 22069295
[TBL] [Abstract][Full Text] [Related]
20. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.
Hillman M; Törn C; Landin-Olsson M;
Clin Exp Immunol; 2009 Aug; 157(2):255-60. PubMed ID: 19604265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
